MedTrace Logo

Comparison of Congenital Pneumonia and Transient Tachypnea of the Newborn

NCT06803355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2025-07-30

No results posted yet for this study

Summary

Accurate and timely differentiation between transient tachypnea of the newborn (TTN) and congenital pneumonia is essential in neonatal care, as it facilitates prompt initiation of appropriate treatment, reduces the risk of complications, and minimizes inappropriate antibiotic use. This study aims to assess the clinical utility of inflammatory markers, including the Systemic Immune-Inflammation Index (SII) and the Systemic Immune-Response Index (SIRI), in distinguishing TTN from congenital pneumonia in neonates. In scenarios where conventional diagnostic methods prove insufficient, these indices may offer clinicians a reliable and objective diagnostic approach, thereby optimizing antibiotic stewardship and reducing the duration of hospitalization.

Conditions

  • Congenital Pneumonia
  • Transient Tachypnea of the Newborn

Interventions

DIAGNOSTIC_TEST

complete blood count, CRP, blood smear test, blood culture, chest X- ray

Inflammation markers obtained from all cases will be evaluated and used to differentiate between transient tachypnea of the newborn and congenital pneumonia.

Sponsors & Collaborators

  • Dr. Behcet Uz Children's Hospital

    lead OTHER

Principal Investigators

  • Şebnem Çalkavur, MD · Dr. Behcet Uz Children's Hospital

Eligibility

Min Age
1 Hour
Max Age
24 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-08
Primary Completion
2025-06-18
Completion
2025-07-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06803355 on ClinicalTrials.gov